Redox Science Meets Medicine at the 26th International Conference on Redox Medicine 2024 this June in Paris
The 26th International Conference on Redox Medicine 2024 will take place this month, on June 27-28 at Fondation Biermans-Lapôtre in Paris, France.
With 41+ communications and participants from 20 different countries, the conference promises a diverse exchange of knowledge and ideas.
The sessions of the conference are organized around key topics, with each speaker addressing a specific aspect of redox research:
Keynote Presentations:
- Miria Ricchetti, Institut Pasteur, France
Redox Medicine: A Biologist Point of View
- Bruce Freeman, University of Pittsburgh, USA
Lessons from a Journey along the Redox Chemistry of Nitrogen Oxides to Drug Development
Redox Signaling and Disease Mechanisms:
- Mario D. Cordero, Universidad Pablo de Olavide, Spain
Mechanism of the SuperInflammasome Complexes in Human Diseases and Redox Signaling
- Christel Marquette, Laboratoire Biosanté U1292 INSERM-CEA-UGA, France
Regulation of the Reactive Species Interactome by Prokineticin Antagonist in Cerebral Dementia
Metabolic Regulation and Health:
- Martin O. Bergo, Karolinska Institutet, Sweden
Antioxidants Stimulate Blood Flow in Tumors
- Tamara Tomin, Technical University of Wien, Austria
Metabolic Regulation by Redox Signaling in the Heart
- Zaher El Beck, Karolinska Institutet and Uppsala University, Sweden
Epigenetic modulators link mitochondrial redox homeostasis to cardiac function in a sex-dependent manner
- Laurent Chatre, ISTCT, CNRS, Université de Caen Normandie, France
The Reactive Species Interactome, Mitochondria, and the Gender-Brain Metabolism Nexus
Redox Biology and Aging:
- Roberta Rizzo, Università degli Studi di Ferrara, Italy
NADH: The Redox Sensor in Aging-Related Disorders
Clinical Applications and Implications:
- Andrew Cumpstey, University of Southampton, United Kingdom
Redox Implications of Supplementary Oxygen during Major Abdominal Surgery
- Daniel Vaiman, DR1 INSERM, Institut Cochin, France
New Insights into the Impact of Oxidative Stress in Hypertensive Diseases of Pregnancy
- Radia Tamarat, Institut de Radioprotection et de Sûreté Nucléaire (IRSN), France
Redox, Radiotherapy, and Biomarkers
Biomarkers in Health & Disease:
- Carole Nicco, President of Redox Medicine Society
Redox Medicine 2024: Biomarkers
- Sayuri Miyamoto, University of São Paulo, Brazil
Identifying Oxidized Lipids in Neurodegenerative Diseases
- Jumana Saleh, Sultan Qaboos University, Oman
Exploring Predictors of HDL Oxidative Stress Functionality in Post-Covid Disease and Relation to Severity
Neurodegenerative Diseases and Drug Development:
- Jeffrey A. Johnson, University of Wisconsin, USA
Targeting the Keap1/Nrf2 Pathway for Treatment of Chronic Neurodegenerative Diseases
- George M. Spyrou, The Cyprus Institute of Neurology & Genetics, Cyprus
Drug repurposing on Alzheimer's Disease & NRF2 Modulation
Pharmaceutical Approaches and Artificial Intelligence:
- Duncan Emerton, Vice-President of Citeline, United Kingdom
Pharma’s Search for Redox-Modulating Therapeutics
- Antonio Vila-Coro, IQVIA, Spain
How to Develop a Drug – From Preclinical to Clinical
- Stéphane Mouchabac, CHU St Antoine DMU Neurosciences and Institut du Cerveau, Paris
Artificial Intelligence in NeuroInflammation, Biomarkers, and Redox Medicine
- Maxime Barat, Université Paris Cité, Hôpital Cochin, France
Artificial Intelligence & Algorithms: Applications in Redox Medicine & Radiology
The Redox Medicine Society is Still Accepting Abstracts
Abstract submissions for poster or short oral presentations are still being accepted. Redox Medicine 2024 conference aims to foster collaboration, facilitate networking, and inspire new research directions in redox medicine.
Supporters 2024: Citeline and Mitologics
For more information about Redox Medicine 2024, please visit: https://www.redox-medicine.com/.